Published February 26, 2013, 12:00 AM


AP photo

This undated image provided by Roche on Friday shows a vial and packaging for the drug Kadcyla. On Friday, the U.S. Food and Drug Administration announced the approval of the first-of-a-kind breast cancer medication that targets tumor cells while sparing healthy ones.

Read the article: New targeted breast cancer drug that targets tumor cells approved